Palo Alto, Calif. – October 31, 2013 – Cooley LLP announced today that it represented NextBio, a Santa Clara-based leader in clinical and genomic informatics, in its acquisition by Illumina. Illumina is a leading developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function.
"With the addition of NextBio's platform upon completion of the acquisition, Illumina will be able to offer customers enterprise level bioinformatics solutions that accelerate the discovery of new associations between the human genome and disease, and ultimately, enable the application of those discoveries within healthcare," states the Illumina company press release.
The Cooley team advising NextBio was led by partner Mehdi Khodadad and included associates Robin Bennett and Alex Kassai. Critical support for the transaction was provided by partner Renee Deming and associate Justin Ho (compensation & benefits); partner Francis Fryscak (antitrust); partner Mark Windfeld-Hansen and associates Michael Baker and Keith Ranta (tax); of counsel Diane Savage, special counsel Chuck Schwab and associates Bryan Berman, Ian O'Neill and J.D. Moss (technology transactions); and senior counsel Lois Voelz and special counsel Ann Polus (employment).
About Cooley LLP
Cooley's attorneys solve legal issues for entrepreneurs, investors and established companies. Clients partner with Cooley on transformative deals, complex IP matters and bet-the-company litigation, often where innovation meets the law.
Cooley has more than 700 lawyers across eleven offices in the United States and China.